跳至主要内容
临床试验/NCT05685342
NCT05685342已完成不适用

Comparison of the Opioid-sparing Effect of Preemptive and Preventive Intravenous Acetaminophen/Ibuprofen Fixed-dose Combination After Robot-assisted Radical Prostatectomy: A Double-blind Randomized Controlled Trial

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2023年2月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
154
试验地点
1
主要终点
Total fentanyl consumption during 24 hours

研究概览

简要总结

This prospective, randomized, double-blinded study is designed to compare opioid-sparing effect of preemptive and preventive intravenous acetaminophen/ibuprofen fixed-dose combination in patients undergoing robot-assisted radical prostatectomy (RARP). We hypothesize that preemptive administration of intravenous acetaminophen/ibuprofen fixed-dose combination can significantly reduce postoperative opioid consumption and pain severity than preventive administration in patients undergoing RARP.

详细描述

Adult patients undergoing elective robot-assisted radical prostatectomy are randomly allocated to receive preemptive administration of acetaminophen (1000 mg)/ibuprofen (300 mg) fixed-dose combination (n=77) or preventive administration (n=77). The preemptive administration group will receive intravenous acetaminophen (1000 mg)/ibuprofen (300 mg) for 15 minutes at the end of induction of anesthesia. The preventive administration group will receive same dosage of drug for same duration when surgical site closure starts.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

An investigator who is not involved in this study randomly allocates the group and another investigator who dose not evaluate clinical endpoints keeps the result of allocation in a sealed envelope.

On the day of study, the second investigator opens the envelope to check allocation and sends a drug and normal saline in identical looking bottles with label only indicating the order of administration.

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients scheduled to undergo elective robot-assisted radical prostatectomy under general anesthesia
  • American Society of Anesthesiologists (ASA) physical classification I-II
  • Consent to IV-patient controlled analgesia use
  • Willingness and ability to sign an informed consent document

排除标准

  • Who do not understand or agree with our study
  • American Society of Anesthesiologists (ASA) physical classification III-IV
  • Chronic usage of opioid analgesics
  • Moderate to severe pain with other cause before surgery
  • Allergies to anesthetic or analgesic medications used in this study
  • Anticipated blood loss larger than 2 liters
  • Need for intensive care after surgery
  • History of gastric ulcer or gastrointestinal bleeding
  • History of liver failure, renal failure or heart failure
  • Current alcoholism
  • Taking anti-coagulation drugs or history of coagulation disease
  • History of bronchial asthma
  • Medical or psychological disease that can affect the treatment response
  • Taking barbitutate or tricyclic antidepressant

研究组 & 干预措施

Preemptive administration group

Experimental

Preemptive administration group will receive intravenous acetaminophen (1000 mg)/ibuprofen (300 mg) for 15 minutes at the end of induction of anesthesia.

干预措施: Acetaminophen/Ibuprofen fixed-dose combination (Drug)

Preventive administration group

Active Comparator

The preventive administration group will receive intravenous acetaminophen (1000 mg)/ibuprofen (300 mg) for 15 minutes when surgical site closure starts.

干预措施: Acetaminophen/Ibuprofen fixed-dose combination (Drug)

结局指标

主要结局

Total fentanyl consumption during 24 hours

时间窗: Postoperative 24 hours

Postoperative fentanyl consumption (mcg) via IV patient controlled analgesia

次要结局

  • Total fentanyl consumption(Postoperative 2, 6, 48 hours)
  • Count of rescue analgesics administration(Postoperative 0-2, 2-6, 6-24, 24-48 hours)
  • Postoperative pain score(Postoperative 2 (resting only), 6, 24, 48 hours)
  • Opioid side effects(Postoperative 0-2, 2-6, 6-24, 24-48 hours)
  • Quality of recovery-15(Postoperative 24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hojin Lee, MD, PhD

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验